Skip to main content
An official website of the United States government

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

Sponsor
University of Rochester NCORP Research Base
Status
Recruiting
NCT ID
NCT07638007
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do not receive TKI therapy.
Condition
Disease/Condition Name Cancer-related Cognitive Dysfunction, Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia, BCR-ABL1 Positive
Investigators
Michelle Janelsins, PhD, Ashley Mack, Karen Mustian, PhD

See list of participating sites